Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
Authors
Keywords
-
Journal
ANNALS OF ONCOLOGY
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2020-12-25
DOI
10.1016/j.annonc.2020.12.007
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mixed-beam approach in locally advanced nasopharyngeal carcinoma: IMRT followed by proton therapy boost versus IMRT-only. Evaluation of toxicity and efficacy
- (2020) Daniela Alterio et al. ACTA ONCOLOGICA
- Network-meta-analysis of chemotherapy in nasopharyngeal carcinoma (MAC-NPC): An update on 8,221 patients.
- (2020) Claire Petit et al. JOURNAL OF CLINICAL ONCOLOGY
- Integrating postradiotherapy plasma Epstein–Barr virus DNA and TNM stage for risk stratification of nasopharyngeal carcinoma to adjuvant therapy
- (2020) E.P. Hui et al. ANNALS OF ONCOLOGY
- NPC‐0501 trial on the value of changing chemoradiotherapy sequence, replacing 5‐fluorouracil with capecitabine, and altering fractionation for patients with advanced nasopharyngeal carcinoma
- (2020) Anne W. M. Lee et al. CANCER
- An optimal posttreatment surveillance strategy for cancer survivors based on an individualized risk-based approach
- (2020) Guan-Qun Zhou et al. Nature Communications
- Clinical Outcome-Related Mutational Signatures Identified by Integrative Genomic Analysis in Nasopharyngeal Carcinoma
- (2020) Wei Dai et al. CLINICAL CANCER RESEARCH
- Role of IMRT/VMAT-Based Dose and Volume Parameters in Predicting 5-Year Local Control and Survival in Nasopharyngeal Cancer Patients
- (2020) Nicola Alessandro Iacovelli et al. Frontiers in Oncology
- Complementary roles of MRI and endoscopic examination in the early detection of nasopharyngeal carcinoma
- (2019) A D King et al. ANNALS OF ONCOLOGY
- Complément de dose de protons pour les cancers du nasopharynx localement évolués : une expérience de l’institut Curie
- (2019) A. Beddok et al. Cancer Radiotherapie
- Locoregional Control and Mild Late Toxicity After Reducing Target Volumes and Radiation Doses in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma Treated With Induction Chemotherapy (IC) Followed by Concurrent Chemoradiotherapy: 10-Year Results of a Phase 2 Study
- (2019) Chong Zhao et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- International Guideline on Dose Prioritization and Acceptance Criteria in Radiotherapy Planning for Nasopharyngeal Carcinoma
- (2019) Anne W. Lee et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma
- (2019) Yuan Zhang et al. NEW ENGLAND JOURNAL OF MEDICINE
- The racial disparity of nasopharyngeal carcinoma based on the database analysis
- (2019) Lei Zhou et al. AMERICAN JOURNAL OF OTOLARYNGOLOGY
- Clinical value of a plasma Epstein–Barr virus DNA assay in the diagnosis of recurrent or metastatic nasopharyngeal carcinoma: a meta-analysis
- (2019) Haiqin Peng et al. BIOSCIENCE REPORTS
- Management of locally recurrent nasopharyngeal carcinoma
- (2019) Anne W.M. Lee et al. CANCER TREATMENT REVIEWS
- Induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: long-term results of a phase III multicentre randomised controlled trial
- (2019) Qi Yang et al. EUROPEAN JOURNAL OF CANCER
- 1108OChemotherapy plus local-regional radiotherapy versus chemotherapy alone in primary metastatic nasopharyngeal carcinoma: A randomized, open-label, phase III trial
- (2019) M Chen et al. ANNALS OF ONCOLOGY
- Selection and Validation of Induction Chemotherapy Beneficiaries Among Patients With T3N0, T3N1, T4N0 Nasopharyngeal Carcinoma Using Epstein-Barr Virus DNA: A Joint Analysis of Real-World and Clinical Trial Data
- (2019) Cheng Xu et al. Frontiers in Oncology
- Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis
- (2019) Catherine de Martel et al. Lancet Global Health
- The effect of histological subtypes on survival outcome in nasopharyngeal carcinoma after extensive follow up
- (2019) San-Gang Wu et al. Annals of Translational Medicine
- Salvage treatment using carbon ion radiation in patients with locoregionally recurrent nasopharyngeal carcinoma: Initial results
- (2018) Jiyi Hu et al. CANCER
- Facility Volume and Survival in Nasopharyngeal Carcinoma
- (2018) Emi J. Yoshida et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Long Term Late Toxicity, Quality Of Life and Emotional Distress In Nasopharyngeal Carcinoma Patients Treated With Intensity-Modulated Radiotherapy
- (2018) Lachlan J. McDowell et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742)
- (2018) Brigette B.Y. Ma et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic Model for Stratification of Radioresistant Nasopharynx Carcinoma to Curative Salvage Radiotherapy
- (2018) You Quan Li et al. JOURNAL OF CLINICAL ONCOLOGY
- Concurrent chemoradiotherapy with nedaplatin versus cisplatin in stage II–IVB nasopharyngeal carcinoma: an open-label, non-inferiority, randomised phase 3 trial
- (2018) Lin-Quan Tang et al. LANCET ONCOLOGY
- Development and validation of a gene expression-based signature to predict distant metastasis in locoregionally advanced nasopharyngeal carcinoma: a retrospective, multicentre, cohort study
- (2018) Xin-Ran Tang et al. LANCET ONCOLOGY
- Treatment outcomes of nasopharyngeal carcinoma in modern era after intensity modulated radiotherapy (IMRT) in Hong Kong: A report of 3328 patients (HKNPCSG 1301 study)
- (2018) K.H. Au et al. ORAL ONCOLOGY
- Suggestions for surveillance and radiation strategy in nasopharyngeal carcinoma treated with IMRT: Based on hazard-rate and patterns of recurrence
- (2018) Tingting Xu et al. ORAL ONCOLOGY
- International guideline for the delineation of the clinical target volumes (CTV) for nasopharyngeal carcinoma
- (2018) Anne W. Lee et al. RADIOTHERAPY AND ONCOLOGY
- Treatment outcomes after reduction of the target volume of intensity-modulated radiotherapy following induction chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: A prospective, multi-center, randomized clinical trial
- (2018) Hongru Yang et al. RADIOTHERAPY AND ONCOLOGY
- A randomized phase III study between sequential versus simultaneous integrated boost intensity-modulated radiation therapy in nasopharyngeal carcinoma
- (2018) Chawalit Lertbutsayanukul et al. STRAHLENTHERAPIE UND ONKOLOGIE
- Association of Human Papillomavirus Status at Head and Neck Carcinoma Subsites With Overall Survival
- (2018) Hong Li et al. JAMA Otolaryngology-Head & Neck Surgery
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Camrelizumab (SHR-1210) alone or in combination with gemcitabine plus cisplatin for nasopharyngeal carcinoma: results from two single-arm, phase 1 trials
- (2018) Wenfeng Fang et al. LANCET ONCOLOGY
- Proposed modifications and incorporation of plasma Epstein-Barr virus DNA improve the TNM staging system for Epstein-Barr virus-related nasopharyngeal carcinoma
- (2018) Rui Guo et al. CANCER
- Head and Neck Cancer Survivorship Care Guideline: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Cancer Society Guideline
- (2017) Larissa Nekhlyudov et al. JOURNAL OF CLINICAL ONCOLOGY
- Safety and Antitumor Activity of Pembrolizumab in Patients With Programmed Death-Ligand 1–Positive Nasopharyngeal Carcinoma: Results of the KEYNOTE-028 Study
- (2017) Chiun Hsu et al. JOURNAL OF CLINICAL ONCOLOGY
- What Is the Best Treatment of Locally Advanced Nasopharyngeal Carcinoma? An Individual Patient Data Network Meta-Analysis
- (2017) Laureen Ribassin-Majed et al. JOURNAL OF CLINICAL ONCOLOGY
- Proton therapy for head and neck cancer: expanding the therapeutic window
- (2017) Jonathan E Leeman et al. LANCET ONCOLOGY
- Analysis of Plasma Epstein–Barr Virus DNA to Screen for Nasopharyngeal Cancer
- (2017) K.C. Allen Chan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Delayed clinical complete response to intensity-modulated radiotherapy in nasopharyngeal carcinoma
- (2017) Wen-Fei Li et al. ORAL ONCOLOGY
- Circulating pre-treatment Epstein-Barr virus DNA as prognostic factor in locally-advanced nasopharyngeal cancer in a non-endemic area
- (2017) Salvatore Alfieri et al. Oncotarget
- The Changing Therapeutic Role of Chemo-radiotherapy for Loco-regionally Advanced Nasopharyngeal Carcinoma from Two/Three-Dimensional Radiotherapy to Intensity-Modulated Radiotherapy: A Network Meta-Analysis
- (2017) Rui You et al. Theranostics
- Chemoradiotherapy Versus Radiotherapy Alone in Stage II Nasopharyngeal Carcinoma: A Systemic Review and Meta-analysis of 2138 Patients
- (2017) Cheng Xu et al. Journal of Cancer
- Global trends in incidence and mortality of nasopharyngeal carcinoma
- (2016) Ling-Ling Tang et al. CANCER LETTERS
- Oligometastases in AJCC stage IVc nasopharyngeal carcinoma: A subset with better overall survival
- (2016) Yun-hong Tian et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial
- (2016) Li Zhang et al. LANCET
- Nasopharyngeal carcinoma
- (2016) Melvin L K Chua et al. LANCET
- Comparison of (18)F-FDG PET/CT, MRI and SPECT in the diagnosis of local residual/recurrent nasopharyngeal carcinoma: A meta-analysis
- (2016) Junbao Wei et al. ORAL ONCOLOGY
- Long-term disease-specific and cognitive quality of life after intensity-modulated radiation therapy: a cross-sectional survey of nasopharyngeal carcinoma survivors
- (2016) Alan Kiang et al. Radiation Oncology
- Prognostic value of 18F-FDG-PET/CT in patients with nasopharyngeal carcinoma: a systematic review and meta-analysis
- (2016) Jie Lin et al. Oncotarget
- The significant survival advantage of female sex in nasopharyngeal carcinoma: a propensity-matched analysis
- (2015) P-Y OuYang et al. BRITISH JOURNAL OF CANCER
- Prognoses and improvement for head and neck cancers diagnosed in Europe in early 2000s: The EUROCARE-5 population-based study
- (2015) Gemma Gatta et al. EUROPEAN JOURNAL OF CANCER
- Long-term late toxicities and quality of life for survivors of nasopharyngeal carcinoma treated with intensity-modulated radiotherapy versus non-intensity-modulated radiotherapy
- (2015) Tai-Lin Huang et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Intensity-modulated proton therapy for nasopharyngeal carcinoma: Decreased radiation dose to normal structures and encouraging clinical outcomes
- (2015) Gary D. Lewis et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Nasopharyngeal Cancer: Molecular Landscape
- (2015) Jeff P. Bruce et al. JOURNAL OF CLINICAL ONCOLOGY
- Establishment and Validation of Prognostic Nomograms for Endemic Nasopharyngeal Carcinoma
- (2015) Lin-Quan Tang et al. JNCI-Journal of the National Cancer Institute
- Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis
- (2015) Pierre Blanchard et al. LANCET ONCOLOGY
- Intensity-modulated radiation therapy versus 2D-RT or 3D-CRT for the treatment of nasopharyngeal carcinoma: A systematic review and meta-analysis
- (2015) Binglan Zhang et al. ORAL ONCOLOGY
- Salvage endoscopic nasopharyngectomy is superior to intensity-modulated radiation therapy for local recurrence of selected T1–T3 nasopharyngeal carcinoma – A case-matched comparison
- (2015) Rui You et al. RADIOTHERAPY AND ONCOLOGY
- Establishment and Validation of Prognostic Nomograms for Endemic Nasopharyngeal Carcinoma
- (2015) Lin-Quan Tang et al. JNCI-Journal of the National Cancer Institute
- Outcome of Patients Undergoing Salvage Surgery for Recurrent Nasopharyngeal Carcinoma: A Meta-analysis
- (2014) Shorook Na’ara et al. ANNALS OF SURGICAL ONCOLOGY
- The genomic landscape of nasopharyngeal carcinoma
- (2014) De-Chen Lin et al. NATURE GENETICS
- Etiological factors of nasopharyngeal carcinoma
- (2014) Sai Wah Tsao et al. ORAL ONCOLOGY
- Prognostic model for survival of local recurrent nasopharyngeal carcinoma with intensity-modulated radiotherapy
- (2013) Y-M Tian et al. BRITISH JOURNAL OF CANCER
- Late toxicities after intensity-modulated radiotherapy for nasopharyngeal carcinoma: patient and treatment-related risk factors
- (2013) L Zeng et al. BRITISH JOURNAL OF CANCER
- A randomized clinical trial comparing prophylactic upper versus whole-neck irradiation in the treatment of patients with node-negative nasopharyngeal carcinoma
- (2013) Jin-Gao Li et al. CANCER
- An International Collaboration to Harmonize the Quantitative Plasma Epstein-Barr Virus DNA Assay for Future Biomarker-Guided Trials in Nasopharyngeal Carcinoma
- (2013) Q.-T. Le et al. CLINICAL CANCER RESEARCH
- The role of plasma Epstein-Barr virus DNA in the management of recurrent nasopharyngeal carcinoma
- (2013) Jimmy Yu Wai Chan et al. LARYNGOSCOPE
- Delineation of the neck node levels for head and neck tumors: A 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelines
- (2013) Vincent Grégoire et al. RADIOTHERAPY AND ONCOLOGY
- Long-term treatment outcome of recurrent nasopharyngeal carcinoma treated with salvage intensity modulated radiotherapy
- (2012) Yi-Jun Hua et al. EUROPEAN JOURNAL OF CANCER
- Accuracy of whole-body FDG-PET and FDG-PET/CT in M staging of nasopharyngeal carcinoma: A systematic review and meta-analysis
- (2012) Ming-Che Chang et al. EUROPEAN JOURNAL OF RADIOLOGY
- Prognostic value of a microRNA signature in nasopharyngeal carcinoma: a microRNA expression analysis
- (2012) Na Liu et al. LANCET ONCOLOGY
- A randomized trial of induction chemotherapy plus concurrent chemoradiotherapy versus induction chemotherapy plus radiotherapy for locoregionally advanced nasopharyngeal carcinoma
- (2012) Pei-Yu Huang et al. ORAL ONCOLOGY
- Prognostic significance of the total dose of cisplatin administered during concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma
- (2012) Herbert H. Loong et al. RADIOTHERAPY AND ONCOLOGY
- Genetic predisposition factors and nasopharyngeal carcinoma risk: A review of epidemiological association studies, 2000–2011
- (2012) Allan Hildesheim et al. SEMINARS IN CANCER BIOLOGY
- Plasma epstein-barr virus DNA concentration and clearance rate as novel prognostic factors for metastatic nasopharyngeal carcinoma
- (2011) Cheng-Lung Hsu et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Eight-Signature Classifier for Prediction of Nasopharyngeal Carcinoma Survival
- (2011) Hai-Yun Wang et al. JOURNAL OF CLINICAL ONCOLOGY
- Concurrent Chemoradiotherapy vs Radiotherapy Alone in Stage II Nasopharyngeal Carcinoma: Phase III Randomized Trial
- (2011) Qiu-Yan Chen et al. JNCI-Journal of the National Cancer Institute
- Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 3 multicentre randomised controlled trial
- (2011) Lei Chen et al. LANCET ONCOLOGY
- Addition of bevacizumab to standard chemoradiation for locoregionally advanced nasopharyngeal carcinoma (RTOG 0615): a phase 2 multi-institutional trial
- (2011) Nancy Y Lee et al. LANCET ONCOLOGY
- Clinical Outcomes and Patterns of Failure After Intensity-Modulated Radiotherapy for Nasopharyngeal Carcinoma
- (2010) Wai Tong Ng et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- How Does Intensity-Modulated Radiotherapy Versus Conventional Two-Dimensional Radiotherapy Influence the Treatment Results in Nasopharyngeal Carcinoma Patients?
- (2010) Shu-Zhen Lai et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Pretreatment Quality of Life As a Predictor of Distant Metastasis and Survival for Patients With Nasopharyngeal Carcinoma
- (2010) Fu-Min Fang et al. JOURNAL OF CLINICAL ONCOLOGY
- A review of human carcinogens—Part B: biological agents
- (2009) Véronique Bouvard et al. LANCET ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now